| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |